Completed PHASE4 INTERVENTIONAL NCT00439855
Enoxaparin Versus Unfractionated Heparin in PCI
Sponsor: Triemli Hospital
Conditions
Coronary Artery Disease
Interventions
Enoxaparin i.v. unfractionated heparin
Updated 4 times since 2017 Last updated: Feb 23, 2007 Started: Sep 30, 2003 Completion: Feb 28, 2006
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by Triemli Hospital and has accumulated 4 data snapshots since 2003. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE4
First recorded
Sep 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Triemli Hospital
Data source: Triemli Hospital
For direct contact, visit the study record on ClinicalTrials.gov .